Organo Corporation
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
363.5K | -0.16% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
231.3K | 0.00% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
176.3K | 0.00% | |
|
TRANSAMERICA FUNDS-Transamerica International Small Cap Value
|
157.3K | +4.31% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
110.6K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
97.5K | 0.00% |
Dividend History 4Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥184 | +39.4% |
| 2024 | ¥132 | +78.4% |
| 2023 | ¥74 | +45.1% |
| 2022 | ¥51 | +64.5% |
| 2021 | ¥31 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥112,069M | ¥132,426M | ¥150,356M | ¥163,269M |
| Gross Profit | ¥28,512M | ¥34,976M | ¥43,841M | ¥55,182M |
| Operating Income | ¥10,850M | ¥15,213M | ¥22,544M | ¥31,121M |
| Pretax Income | ¥12,823M | ¥16,194M | ¥23,873M | ¥32,604M |
| Net Income | ¥9,210M | ¥11,730M | ¥17,310M | ¥24,150M |
| EPS | ¥200.67 | ¥255.77 | ¥376.92 | ¥525.37 |
| Operating Margin | 9.68% | 11.49% | 14.99% | 19.06% |
| Balance Sheet | ||||
| Total Assets | ¥130,506M | ¥164,854M | ¥182,703M | ¥194,396M |
| Total Equity | ¥75,836M | ¥86,169M | ¥101,927M | ¥120,947M |
| Total Liabilities | ¥54,670M | ¥78,685M | ¥80,776M | ¥73,449M |
| Cash | ¥20,198M | ¥15,558M | ¥17,642M | ¥16,751M |
| Interest-bearing Debt | ¥15,628M | ¥33,019M | ¥36,465M | ¥22,557M |
| Equity Ratio | 58.11% | 52.27% | 55.79% | 62.22% |
| D/E Ratio | 0.21 | 0.38 | 0.36 | 0.19 |
| Cash Flow | ||||
| Operating CF | ¥10,787M | -¥18,536M | ¥3,726M | ¥21,100M |
| Investing CF | -¥1,520M | -¥1,309M | -¥1,415M | -¥2,130M |
| Financing CF | -¥2,586M | ¥14,706M | -¥641M | -¥20,821M |
| Free CF | ¥7,989M | -¥19,988M | ¥2,079M | ¥18,411M |
| Efficiency | ||||
| ROE | 12.14% | 13.61% | 16.98% | 19.97% |
| ROA | 7.06% | 7.12% | 9.47% | 12.42% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 6368
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥14,500
Rating Score: - (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Organo Corporation engages in water treatment engineering and performance product businesses in Japan, Taiwan, China, Southeast Asia, and internationally. The company offers pure water systems, such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop and cabinet-type pure water systems, electrodeionization high-purity water systems, cartridge water purifiers, and two-stage RO systems; ultrapure water systems, including desktop and cabinet-type ultrapure water systems, and final polishing units; and other equipment comprising homogenizers, electroconductivity and resistivity meters, and ion exchange filters, as well as marine scrubber wastewater treatment and continuous aerobic granular sludge systems. It also provides water, wastewater, and RO water treatment chemicals; industrial filters consisting of micro filter, sanitary, polypropylene, and plastic housings, as well as micro filters; and commercial water purifiers. In addition, the company offers ultrapure and multi-functional water production systems, wastewater treatment systems, ultra pure ion exchange resin for purifying electronic materials, valuable resource recovery systems, and organic solvent refining systems; purified and UF water production and supply systems, water for injection production and supply systems, and pharmaceutical water system consulting services; water supply and sewage treatment facility products; condensate filters and demineralizers, reactor water and fuel pool cleanup, makeup water, and waste water treatment systems; and sugar refining and decolorization, sugar desalination, amino and acidic sugar refining, and sugar separation equipment. The company was formerly known as Japan Organo Co., Ltd. and changed its name to Organo Corporation in 1966. Organo Corporation was incorporated in 1941 and is headquartered in Koto, Japan.